BackCelularity- Warrants (16/07/2026) Overview

Celularity- Warrants (16/07/2026) Total Assets

Celularity- Warrants (16/07/2026)'s total assets is $110M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$107.33M
19.11% YoYΔ $-25.35M vs prior year quarter

Peer average

Loading

Celularity- Warrants (16/07/2026) Total Assets History

Loading

Celularity- Warrants (16/07/2026) vs. peers: Total Assets Comparison

Loading

Celularity- Warrants (16/07/2026) Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Celularity- Warrants (16/07/2026) (CELUW) FAQ

Celularity- Warrants (16/07/2026)'s total assets stands at $110M as of December 2025. That compares with $130M in the prior-year period — down 19.1% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Celularity- Warrants (16/07/2026) reported $110M in total assets versus $130M a year earlier — a 19.1% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $130M in the prior-year period — down 19.1% year over year. Sustained growth in total assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Celularity- Warrants (16/07/2026)'s total assets evolved across reporting periods, while the comparison chart places CELUW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, total assets is commonly used to spot outliers. Celularity- Warrants (16/07/2026)'s reading of $110M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.